当前位置:首页 - 行情中心 - 海昇药业(920656) - 财务分析 - 现金流量表

海昇药业

(920656)

  

流通市值:11.93亿  总市值:14.61亿
流通股本:8162.86万   总股本:1.00亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金93,879,422.7334,916,362138,931,947.9391,582,662.68
  收到其他与经营活动有关的现金1,105,500.37545,873.828,317,631.848,052,732.73
  经营活动现金流入小计94,984,923.135,462,235.82147,249,579.7799,635,395.41
  购买商品、接受劳务支付的现金28,675,979.1212,351,791.954,493,312.9737,543,157.62
  支付给职工以及为职工支付的现金17,203,186.128,807,118.2237,683,370.8523,984,085.96
  支付的各项税费17,784,070.298,417,874.213,199,861.1713,715,871.36
  支付其他与经营活动有关的现金3,781,406.31,400,348.886,544,331.885,462,383.6
  经营活动现金流出小计67,444,641.8330,977,133.2111,920,876.8780,705,498.54
  经营活动产生的现金流量净额27,540,281.274,485,102.6235,328,702.918,929,896.87
二、投资活动产生的现金流量:
  取得投资收益收到的现金3,666,868.062,062,125.756,984,077.423,111,195.97
  收到的其他与投资活动有关的现金2,046,000,0001,000,000,0002,515,000,0001,831,000,000
  投资活动现金流入小计2,049,666,868.061,002,062,125.752,521,984,077.421,834,111,195.97
  购建固定资产、无形资产和其他长期资产支付的现金5,606,476.795,372,837.3712,952,404.711,265,115.09
  支付其他与投资活动有关的现金1,991,000,000945,000,0002,570,000,0002,191,000,000
  投资活动现金流出小计1,996,606,476.79950,372,837.372,582,952,404.72,202,265,115.09
  投资活动产生的现金流量净额53,060,391.2751,689,288.38-60,968,327.28-368,153,919.12
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金40,000,000-20,000,00020,000,000
  支付其他与筹资活动有关的现金--19,698,10019,698,100
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计40,000,000-39,698,10039,698,100
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额-40,000,000--39,698,100-39,698,100
四、汇率变动对现金及现金等价物的影响-1,573,262.05-732,110.49-696,089.16-36,256.69
五、现金及现金等价物净增加额39,027,410.4955,442,280.51-66,033,813.54-388,958,378.94
  加:期初现金及现金等价物余额380,610,266.95380,610,266.95446,644,080.49446,644,080.49
  期末现金及现金等价物余额419,637,677.44436,052,547.46380,610,266.9557,685,701.55
补充资料:
  净利润47,021,107.42-69,456,983.52-
  资产减值准备-18,487.22-472,839.65-
  固定资产和投资性房地产折旧8,559,162.95-17,164,612.59-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧8,559,162.95-17,164,612.59-
  无形资产摊销444,390.06-510,435.5-
  长期待摊费用摊销88,225.02-176,450.04-
  公允价值变动损失---216,333-
  财务费用1,897,233.92-696,089.16-
  投资损失-3,450,535.06--6,984,077.42-
  递延所得税27,111.8--877,694.43-
  其中:递延所得税资产减少27,111.8--877,694.43-
  存货的减少-1,262,347.05--9,946,728.03-
  经营性应收项目的减少-23,733,298.18--47,773,503.47-
  经营性应付项目的增加-2,619,259.4-10,840,283.23-
  其他418,923.09-1,347,193.45-
  现金的期末余额419,637,677.44-380,610,266.95-
  减:现金的期初余额380,610,266.95-446,644,080.49-
  现金及现金等价物的净增加额39,027,410.49--66,033,813.54-
公告日期2026-08-202026-04-162026-04-162025-10-27
审计意见(境内)标准无保留意见
TOP↑